Appropriate Information Disclosure and Management

Appropriate Information Disclosure

Sumitomo Dainippon Pharma recognizes the importance of transparency in earning the trust of society, and as such, strives to disclose corporate information in a timely, appropriate and fair manner to its stakeholders.

We undertake disclosure of information under due recognition of Japan's Financial Instruments and Exchange Act, the Timely Disclosure Rules of the Tokyo Stock Exchange (TSE), our in-house regulations for management and disclosure of information, and other rules.

Information that requires timely disclosure, such as the Company's financial results, is promptly disclosed through the Timely Disclosure Network (TDnet) system of the Tokyo Stock Exchange and also published on our corporate website.

We also actively disclose information not requiring timely disclosure, including corporation information and product information, through news releases to media outlets and our own corporate website.

For medical professionals as well as patients and their families, Sumitomo Dainippon Pharma provides information in Japanese on various diseases through its Medical Information Website and Sumitomo Dainippon Pharma's Health Information Website (Japanese only), which are linked to its corporate website, and other media such as television monitors installed in hospitals and clinics.

Protecting and Managing Personal Information

Sumitomo Dainippon Pharma has a privacy policy in place, and based on its internal rules governing the management of personal information, properly handles personal information acquired through its business activities from medical professionals, product users, business partners, shareholders and employees according to all applicable laws, ordinances, regulations and social norms. In addition, Sumitomo Dainippon Pharma has built a solid management structure that includes an executive officer in charge of personal information management, a Personal Information Management Committee and a personal information hotline. Together with raising awareness among its employees, Sumitomo Dainippon Pharma has also developed operational manuals for each business division and department as part of its commitment to actively promoting the protection of all personal information it handles.

Information Security

"Information" is an essential asset in our corporate activities, and how it is utilized and protected is of particular importance to the Company. We have settled global policies for records and information management as well as various rules for information security to minimize risks. In addition, each Group company enforces its own equivalent set of rules. As part of its information security measures, Sumitomo Dainippon Pharma constantly reviews its technological protections as well as internal rules and standards in light of social changes and advances made in information technologies. We also work to maintain high levels of security at Group companies.

As part of our physical measures to protect information, we have moved file servers and other information storage devices to robust datacenters and have developed redundancy systems to ensure all systems continue to function even during a failure.

Since we started using a shared global networking system, we have adjusted to the level of information security policies and standards established by Japan, the United States and Europe, and strengthened our operational practices. At the same time, we are revising our standards to match ISO27001, which is an international standard on information security.

We also focus on education with the aim that employees strongly recognize the importance of information security and ensure full compliance with rules and regulations. Moreover, we continue providing information security training over our intranet to keep awareness about information security high.